Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 177

1.

Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma.

Fan ST, Lo CM, Lai EC, Chu KM, Liu CL, Wong J.

N Engl J Med. 1994 Dec 8;331(23):1547-52.

2.

Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma.

Ziegler TR.

JPEN J Parenter Enteral Nutr. 1996 Jan-Feb;20(1):91-2.

PMID:
8788271
3.

Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths.

Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK, Yeung C, Wong J.

Ann Surg. 1999 Mar;229(3):322-30.

4.

Effects of branched-chain amino acids-enriched nutrient support for patients undergoing liver resection for hepatocellular carcinoma.

Okabayashi T, Nishimori I, Sugimoto T, Maeda H, Dabanaka K, Onishi S, Kobayashi M, Hanazaki K.

J Gastroenterol Hepatol. 2008 Dec;23(12):1869-73. doi: 10.1111/j.1440-1746.2008.05504.x. Epub 2008 Aug 20.

PMID:
18717761
5.

Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis.

Fan ST, Lai EC, Lo CM, Ng IO, Wong J.

Arch Surg. 1995 Feb;130(2):198-203.

PMID:
7848092
6.

Model for End-stage Liver Disease score fails to predict perioperative outcome after hepatic resection for hepatocellular carcinoma in patients without cirrhosis.

Teh SH, Sheppard BC, Schwartz J, Orloff SL.

Am J Surg. 2008 May;195(5):697-701. doi: 10.1016/j.amjsurg.2007.05.054.

PMID:
18367132
7.

Prospective randomized controlled study of short-term perioperative oral nutrition with branched chain amino acids in patients undergoing liver surgery.

Ishikawa Y, Yoshida H, Mamada Y, Taniai N, Matsumoto S, Bando K, Mizuguchi Y, Kakinuma D, Kanda T, Tajiri T.

Hepatogastroenterology. 2010 May-Jun;57(99-100):583-90.

PMID:
20698232
8.

Risk factors for perioperative morbidity and mortality after extended hepatectomy for hepatocellular carcinoma.

Wei AC, Tung-Ping Poon R, Fan ST, Wong J.

Br J Surg. 2003 Jan;90(1):33-41.

PMID:
12520572
9.
10.

Prospective evaluation of Pringle maneuver in hepatectomy for liver tumors by a randomized study.

Man K, Fan ST, Ng IO, Lo CM, Liu CL, Wong J.

Ann Surg. 1997 Dec;226(6):704-11; discussion 711-3.

11.

Clarification of risk factors for hepatectomy in patients with hepatocellular carcinoma.

Ishikawa M, Yogita S, Miyake H, Fukuda Y, Harada M, Wada D, Tashiro S.

Hepatogastroenterology. 2002 Nov-Dec;49(48):1625-31.

PMID:
12397750
12.

Splenic arterial ligation prevents liver injury after a major hepatectomy by a reduction of surplus portal hypertension in hepatocellular carcinoma patients with cirrhosis.

Sato Y, Kobayashi T, Nakatsuka H, Yamamoto S, Oya H, Watanabe T, Hatakeyama K.

Hepatogastroenterology. 2001 May-Jun;48(39):831-5.

PMID:
11462934
13.

High preoperative serum alanine transferase levels: effect on the risk of liver resection in Child grade A cirrhotic patients.

Noun R, Jagot P, Farges O, Sauvanet A, Belghiti J.

World J Surg. 1997 May;21(4):390-4; discussion 395.

PMID:
9143570
14.

The benefit of the supplementation of perioperative branched-chain amino acids in patients with surgical management for hepatocellular carcinoma: a preliminary study.

Okabayashi T, Nishimori I, Sugimoto T, Iwasaki S, Akisawa N, Maeda H, Ito S, Onishi S, Ogawa Y, Kobayashi M, Hanazaki K.

Dig Dis Sci. 2008 Jan;53(1):204-9. Epub 2007 May 18.

PMID:
17510798
15.

Longterm prognosis after hepatic resection for small hepatocellular carcinoma.

Shimozawa N, Hanazaki K.

J Am Coll Surg. 2004 Mar;198(3):356-65.

PMID:
14992736
16.
17.

No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach.

Torzilli G, Makuuchi M, Inoue K, Takayama T, Sakamoto Y, Sugawara Y, Kubota K, Zucchi A.

Arch Surg. 1999 Sep;134(9):984-92.

PMID:
10487594
18.

Risk factors and management of ascites after liver resection to treat hepatocellular carcinoma.

Ishizawa T, Hasegawa K, Kokudo N, Sano K, Imamura H, Beck Y, Sugawara Y, Makuuchi M.

Arch Surg. 2009 Jan;144(1):46-51. doi: 10.1001/archsurg.2008.511.

PMID:
19153324
19.

Limits and benefits of exclusive transthoracic hepatectomy approach for patients with hepatocellular carcinoma.

Pocard M, Sauvanet A, Regimbeau JM, Duwat O, Farges O, Belghiti J.

Hepatogastroenterology. 2002 Jan-Feb;49(43):32-5.

PMID:
11941979
20.

A comparative study of postoperative complications after hepatectomy in patients with and without chronic liver disease.

Midorikawa Y, Kubota K, Takayama T, Toyoda H, Ijichi M, Torzilli G, Mori M, Makuuchi M.

Surgery. 1999 Sep;126(3):484-91.

PMID:
10486600

Supplemental Content

Support Center